Literature DB >> 2563718

Seroprevalence of HTLV-I in Portugal and evidence of double retrovirus infection of a healthy donor.

E A Cardoso1, M Robert-Guroff, G Franchini, S Gartner, J F Moura-Nunes, R C Gallo, A M Terrinha.   

Abstract

The prevalence of antibodies to HTLV-I in 5,475 Portuguese from 6 regions spanning the country was studied. Overall seroprevalence was 0.55%, indicating that Portugal is not an endemic area for this virus. Seropositives were distributed throughout the country, and no geographic clustering was observed. The seroprevalence of individuals who had lived in former Portuguese colonies in Africa (0.7%) was significantly higher than that of individuals who had not been in Africa (0.36%). An increase in seroprevalence with age was noted, and more females than males were antibody-positive, though not significantly so. Serum from one donor (1711), originating from Guinea-Bissau, was shown by Western blot and radioimmune precipitation to react with various proteins of HTLV-I, HIV-1 and -2, and SIV. Based on the serologic profiles and isolation of bona fide HTLV-I from her lymphocytes (confirmed by immunologic analysis, molecular cloning of the provirus and restriction enzyme analysis and sequencing of the DNA), together with the reactivity of her sera with an HIV-2 isolate obtained from her husband, we conclude that this donor was doubly infected with HTLV-I and HIV-2, rather than being the host to an as yet unidentified retrovirus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2563718     DOI: 10.1002/ijc.2910430204

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  Immunogenicity and protective efficacy of recombinant human T-cell leukemia/lymphoma virus type 1 NYVAC and naked DNA vaccine candidates in squirrel monkeys (Saimiri sciureus).

Authors:  M Kazanji; J Tartaglia; G Franchini; B de Thoisy; A Talarmin; H Contamin; A Gessain; G de Thé
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  HTLV Tax gene expression in patients with lymphoproliferative disorders.

Authors:  E A Cardoso; N Miranda; P Gameiro; M J Frade; M Figueiredo; A Parreira
Journal:  J Clin Pathol       Date:  1996-11       Impact factor: 3.411

Review 3.  Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.

Authors:  Nicolas Legrand; Skye McGregor; Rowena Bull; Sahar Bajis; Braulio Mark Valencia; Amrita Ronnachit; Lloyd Einsiedel; Antoine Gessain; John Kaldor; Marianne Martinello
Journal:  Clin Microbiol Rev       Date:  2022-02-23       Impact factor: 50.129

4.  Isolation of a novel simian T-cell lymphotropic virus from Pan paniscus that is distantly related to the human T-cell leukemia/lymphotropic virus types I and II.

Authors:  A Giri; P Markham; L Digilio; G Hurteau; R C Gallo; G Franchini
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations.

Authors:  A Gessain; R C Gallo; G Franchini
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.